Fox Christine Ann's Form 4 filing
Mereo BioPharma Group plc (MREO) · filed Jun 27, 2024
- Accession no.
- 0000950170-24-078467
- Filed
- Jun 27, 2024
- Trade date
- Jun 25-26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $147.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fox Christine AnnCIK 0002005755 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −12,990 | $3.69 | −$47,933.1 | 87,010 | Direct | |
| Jun 26, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −29,439 | $3.39 | −$99,798.21 | 57,571 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.